The verified properties also explained, why certain single-gene targeted therapies, for example, the RB- and PTEN-treatment, might not always inhibit the growth of pancreatic cancer cells, due to the crosstalk of different signaling pathways, even if some pathway is blocked. Here, RB1 is linked to familial pancreatic carcinoma.